Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
Abstract Objectives The intestinal epithelium compartmentalizes the sterile bloodstream and the commensal bacteria in the gut. Accumulating evidence suggests that this barrier is impaired in sepsis, aggravating systemic inflammation. Previous studies reported that cathelicidin is differentially expr...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-020-2754-5 |
id |
doaj-7d62813e15f84a7bb7e67e903aed1b8b |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jeffery Ho Hung Chan Yonghao Liang Xiaodong Liu Lin Zhang Qing Li Yuchen Zhang Judeng Zeng Felix N. Ugwu Idy H. T. Ho Wei Hu Johnny C. W. Yau Sunny H. Wong Wai Tat Wong Lowell Ling Chi H. Cho Richard L. Gallo Tony Gin Gary Tse Jun Yu Matthew T. V. Chan Czarina C. H. Leung William K. K. Wu |
spellingShingle |
Jeffery Ho Hung Chan Yonghao Liang Xiaodong Liu Lin Zhang Qing Li Yuchen Zhang Judeng Zeng Felix N. Ugwu Idy H. T. Ho Wei Hu Johnny C. W. Yau Sunny H. Wong Wai Tat Wong Lowell Ling Chi H. Cho Richard L. Gallo Tony Gin Gary Tse Jun Yu Matthew T. V. Chan Czarina C. H. Leung William K. K. Wu Cathelicidin preserves intestinal barrier function in polymicrobial sepsis Critical Care LL-37 Sepsis Bacterial translocation Antimicrobial peptide |
author_facet |
Jeffery Ho Hung Chan Yonghao Liang Xiaodong Liu Lin Zhang Qing Li Yuchen Zhang Judeng Zeng Felix N. Ugwu Idy H. T. Ho Wei Hu Johnny C. W. Yau Sunny H. Wong Wai Tat Wong Lowell Ling Chi H. Cho Richard L. Gallo Tony Gin Gary Tse Jun Yu Matthew T. V. Chan Czarina C. H. Leung William K. K. Wu |
author_sort |
Jeffery Ho |
title |
Cathelicidin preserves intestinal barrier function in polymicrobial sepsis |
title_short |
Cathelicidin preserves intestinal barrier function in polymicrobial sepsis |
title_full |
Cathelicidin preserves intestinal barrier function in polymicrobial sepsis |
title_fullStr |
Cathelicidin preserves intestinal barrier function in polymicrobial sepsis |
title_full_unstemmed |
Cathelicidin preserves intestinal barrier function in polymicrobial sepsis |
title_sort |
cathelicidin preserves intestinal barrier function in polymicrobial sepsis |
publisher |
BMC |
series |
Critical Care |
issn |
1364-8535 |
publishDate |
2020-02-01 |
description |
Abstract Objectives The intestinal epithelium compartmentalizes the sterile bloodstream and the commensal bacteria in the gut. Accumulating evidence suggests that this barrier is impaired in sepsis, aggravating systemic inflammation. Previous studies reported that cathelicidin is differentially expressed in various tissues in sepsis. However, its role in sepsis-induced intestinal barrier dysfunction has not been investigated. Design To examine the role of cathelicidin in polymicrobial sepsis, cathelicidin wild-(Cnlp +/+) and knockout (Cnlp −/−) mice underwent cecal-ligation and puncture (CLP) followed by the assessment of septic mortality and morbidity as well as histological, biochemical, immunological, and transcriptomic analyses in the ileal tissues. We also evaluated the prophylactic and therapeutic efficacies of vitamin D3 (an inducer of endogenous cathelicidin) in the CLP-induced murine polymicrobial sepsis model. Results The ileal expression of cathelicidin was increased by three-fold after CLP, peaking at 4 h. Knockout of Cnlp significantly increased 7-day mortality and was associated with a higher murine sepsis score. Alcian-blue staining revealed a reduced number of mucin-positive goblet cells, accompanied by reduced mucin expression. Increased number of apoptotic cells and cleavage of caspase-3 were observed. Cnlp deletion increased intestinal permeability to 4kD fluorescein-labeled dextran and reduced the expression of tight junction proteins claudin-1 and occludin. Notably, circulating bacterial DNA load increased more than two-fold. Transcriptome analysis revealed upregulation of cytokine/inflammatory pathway. Depletion of Cnlp induced more M1 macrophages and neutrophils compared with the wild-type mice after CLP. Mice pre-treated with cholecalciferol (an inactive form of vitamin D3) or treated with 1alpha, 25-dihydroxyvitamin D3 (an active form of VD3) had decreased 7-day mortality and significantly less severe symptoms. Intriguingly, the administration of cholecalciferol after CLP led to worsened 7-day mortality and the associated symptoms. Conclusions Endogenous cathelicidin promotes intestinal barrier integrity accompanied by modulating the infiltration of neutrophils and macrophages in polymicrobial sepsis. Our data suggested that 1alpha, 25-dihydroxyvitamin D3 but not cholecalciferol is a potential therapeutic agent for treating sepsis. |
topic |
LL-37 Sepsis Bacterial translocation Antimicrobial peptide |
url |
https://doi.org/10.1186/s13054-020-2754-5 |
work_keys_str_mv |
AT jefferyho cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT hungchan cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT yonghaoliang cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT xiaodongliu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT linzhang cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT qingli cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT yuchenzhang cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT judengzeng cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT felixnugwu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT idyhtho cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT weihu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT johnnycwyau cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT sunnyhwong cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT waitatwong cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT lowellling cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT chihcho cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT richardlgallo cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT tonygin cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT garytse cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT junyu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT matthewtvchan cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT czarinachleung cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis AT williamkkwu cathelicidinpreservesintestinalbarrierfunctioninpolymicrobialsepsis |
_version_ |
1724270647016685568 |
spelling |
doaj-7d62813e15f84a7bb7e67e903aed1b8b2021-02-14T12:20:08ZengBMCCritical Care1364-85352020-02-0124111610.1186/s13054-020-2754-5Cathelicidin preserves intestinal barrier function in polymicrobial sepsisJeffery Ho0Hung Chan1Yonghao Liang2Xiaodong Liu3Lin Zhang4Qing Li5Yuchen Zhang6Judeng Zeng7Felix N. Ugwu8Idy H. T. Ho9Wei Hu10Johnny C. W. Yau11Sunny H. Wong12Wai Tat Wong13Lowell Ling14Chi H. Cho15Richard L. Gallo16Tony Gin17Gary Tse18Jun Yu19Matthew T. V. Chan20Czarina C. H. Leung21William K. K. Wu22Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Medicine and Therapeutics, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongLaboratory of Molecular Pharmacology, School of Pharmacy, Southwest Medical UniversityDepartment of Dermatology, The University of CaliforniaDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Medicine and Therapeutics, The Chinese University of Hong KongState Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Sciences, and Centre for Gut Microbiota Research, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong KongAbstract Objectives The intestinal epithelium compartmentalizes the sterile bloodstream and the commensal bacteria in the gut. Accumulating evidence suggests that this barrier is impaired in sepsis, aggravating systemic inflammation. Previous studies reported that cathelicidin is differentially expressed in various tissues in sepsis. However, its role in sepsis-induced intestinal barrier dysfunction has not been investigated. Design To examine the role of cathelicidin in polymicrobial sepsis, cathelicidin wild-(Cnlp +/+) and knockout (Cnlp −/−) mice underwent cecal-ligation and puncture (CLP) followed by the assessment of septic mortality and morbidity as well as histological, biochemical, immunological, and transcriptomic analyses in the ileal tissues. We also evaluated the prophylactic and therapeutic efficacies of vitamin D3 (an inducer of endogenous cathelicidin) in the CLP-induced murine polymicrobial sepsis model. Results The ileal expression of cathelicidin was increased by three-fold after CLP, peaking at 4 h. Knockout of Cnlp significantly increased 7-day mortality and was associated with a higher murine sepsis score. Alcian-blue staining revealed a reduced number of mucin-positive goblet cells, accompanied by reduced mucin expression. Increased number of apoptotic cells and cleavage of caspase-3 were observed. Cnlp deletion increased intestinal permeability to 4kD fluorescein-labeled dextran and reduced the expression of tight junction proteins claudin-1 and occludin. Notably, circulating bacterial DNA load increased more than two-fold. Transcriptome analysis revealed upregulation of cytokine/inflammatory pathway. Depletion of Cnlp induced more M1 macrophages and neutrophils compared with the wild-type mice after CLP. Mice pre-treated with cholecalciferol (an inactive form of vitamin D3) or treated with 1alpha, 25-dihydroxyvitamin D3 (an active form of VD3) had decreased 7-day mortality and significantly less severe symptoms. Intriguingly, the administration of cholecalciferol after CLP led to worsened 7-day mortality and the associated symptoms. Conclusions Endogenous cathelicidin promotes intestinal barrier integrity accompanied by modulating the infiltration of neutrophils and macrophages in polymicrobial sepsis. Our data suggested that 1alpha, 25-dihydroxyvitamin D3 but not cholecalciferol is a potential therapeutic agent for treating sepsis.https://doi.org/10.1186/s13054-020-2754-5LL-37SepsisBacterial translocationAntimicrobial peptide |